Zurcher Kantonalbank (Zurich Cantonalbank) - LEXICON PHARMACEUTICALS INC ownership

LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 113 filers reported holding LEXICON PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.86 and the average weighting 0.1%.

Quarter-by-quarter ownership
Zurcher Kantonalbank (Zurich Cantonalbank) ownership history of LEXICON PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$22,658
-52.4%
20,7870.0%0.00%
Q2 2023$47,602
-5.8%
20,7870.0%0.00%
Q1 2023$50,512
-27.5%
20,787
-43.0%
0.00%
Q4 2022$69,677
+132.3%
36,480
+187.5%
0.00%
Q3 2022$30,000
+25.0%
12,6880.0%0.00%
Q2 2022$24,000
-11.1%
12,6880.0%0.00%
Q1 2022$27,000
-46.0%
12,6880.0%0.00%
Q4 2021$50,000
+525.0%
12,688
+201.2%
0.00%
Q1 2020$8,000
-52.9%
4,2130.0%0.00%
Q4 2019$17,000
+30.8%
4,2130.0%0.00%
Q3 2019$13,000
-50.0%
4,2130.0%0.00%
Q2 2019$26,000
+13.0%
4,2130.0%0.00%
Q1 2019$23,000
-17.9%
4,2130.0%0.00%
Q4 2018$28,000
-37.8%
4,2130.0%0.00%
Q3 2018$45,000
-11.8%
4,2130.0%0.00%
Q2 2018$51,000
+41.7%
4,2130.0%0.00%
Q1 2018$36,000
+176.9%
4,213
+215.1%
0.00%
Q4 2017$13,000
-18.8%
1,3370.0%0.00%
Q3 2017$16,000
-27.3%
1,3370.0%0.00%
Q2 2017$22,000
+15.8%
1,3370.0%0.00%
Q1 2017$19,000
+5.6%
1,3370.0%0.00%
Q4 2016$18,000
-25.0%
1,3370.0%0.00%
Q3 2016$24,000
+71.4%
1,337
+38.8%
0.00%
Q2 2016$14,000
+16.7%
9630.0%0.00%
Q1 2016$12,000
-7.7%
9630.0%0.00%
Q4 2015$13,000
+30.0%
9630.0%0.00%
Q3 2015$10,0009630.00%
Other shareholders
LEXICON PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Artal Group S.A. 71,178,364$280,443,0007.61%
BVF INC/IL 14,360,000$56,578,0002.05%
Integral Health Asset Management, LLC 200,000$788,0000.22%
Eversept Partners, LP 797,694$3,142,9140.20%
NEA Management Company, LLC 2,382,286$9,386,0000.19%
PINNACLE ASSOCIATES LTD 2,127,662$8,383,0000.14%
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 35,714$141,0000.06%
Virtus ETF Advisers LLC 41,584$164,0000.06%
Pegasus Asset Management, Inc. 10,000$39,0000.02%
GSA CAPITAL PARTNERS LLP 31,562$124,0000.02%
View complete list of LEXICON PHARMACEUTICALS INC shareholders